Related references
Note: Only part of the references are listed.IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
Suren Sarkissyan et al.
PLOS ONE (2014)
Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer
Xiaodong Tian et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors
Wen-Wei Chang et al.
BREAST CANCER RESEARCH (2013)
Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets
Caroline Gest et al.
CANCER LETTERS (2012)
The Prognostic Impact of TGF-β1, Fascin, NF-κB and PKC-ζ Expression in Soft Tissue Sarcomas
Andrej Valkov et al.
PLOS ONE (2011)
mTOR Complex Component Rictor Interacts with PKCζ and Regulates Cancer Cell Metastasis
Fei Zhang et al.
CANCER RESEARCH (2010)
Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators
Ling Huang et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis
Jing Wu et al.
INVESTIGATIONAL NEW DRUGS (2010)
RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones
Marco Della Peruta et al.
MOLECULAR CANCER (2010)
Coordination of glioblastoma cell motility by PKCi
R. Mitchell Baldwin et al.
MOLECULAR CANCER (2010)
β3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer
Swayamjot Kaur et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomast
Karolina Partheen et al.
BMC CANCER (2009)
Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
Niels Eckstein et al.
CANCER RESEARCH (2009)
Role of protein kinase C-iota in transformed non-malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 cells
H. Y. Win et al.
CELL PROLIFERATION (2009)
Atypical Protein Kinase C Activity Is Required for Extracellular Matrix Degradation and Invasion by Src-Transformed Cells
Elena M. Rodriguez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Reduction of protein kinase C ζ inhibits migration and invasion of human glioblastoma cells
Hua Guo et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Down-regulation of PKCζ expression inhibits chemotaxis signal transduction in human lung cancer cells
Ying Liu et al.
LUNG CANCER (2009)
Local Expression of Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, and Estrogen Receptor Alpha in Ovarian Cancer
Yuan An et al.
ONKOLOGIE (2009)
Integrin αvβ3-mediated transcriptional regulation of TIMP-1 in a human ovarian cancer cell line
Dong Seok Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Atypical protein kinase C phosphorylates IKKαβ in transformed non-malignant and malignant prostate cell survival
Hla Y. Win et al.
CANCER LETTERS (2008)
Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas
Karolina Partheen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer
Dimitrios Spentzos et al.
ENDOCRINE-RELATED CANCER (2007)
aPKCζ cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia
D. Grifoni et al.
ONCOGENE (2007)
Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells
Takahiro Inoue et al.
MOLECULAR ENDOCRINOLOGY (2006)
Protein kinase C mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase
Ezra Eddy Wyssant Cohen et al.
CANCER RESEARCH (2006)
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCι as a biomarker and potential oncogene in ovarian carcinoma
Lin Zhang et al.
CANCER RESEARCH (2006)
Akt signaling and cancer: Surviving but not moving on
A Toker et al.
CANCER RESEARCH (2006)
Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer
AM Eder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
p62 modulates Akt activity via association with PKCξ in neuronal survival and differentiation
I Joung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Protein kinase C ζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells
RH Sun et al.
CANCER RESEARCH (2005)
Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas
A Ouban et al.
HUMAN PATHOLOGY (2003)
Protein kinase C lambda/iota (PKC lambda/iota): A PKC isotype essential for the development of multicellular organisms
A Suzuki et al.
JOURNAL OF BIOCHEMISTRY (2003)
Protein kinase C zeta (PKC zeta): Activation mechanisms and cellular functions
T Hirai et al.
JOURNAL OF BIOCHEMISTRY (2003)
Role of ζPKC in B-cell signaling and function
P Martin et al.
EMBO JOURNAL (2002)
Atypical protein kinase C is involved in the evolutionarily conserved PAR protein complex and plays a critical role in establishing epithelia-specific junctional structures
A Suzuki et al.
JOURNAL OF CELL BIOLOGY (2001)
The atypical protein kinase Cs - Functional specificity mediated by specific protein adapters
J Moscat et al.
EMBO REPORTS (2000)
Protein kinase C ζ isoform is critical for proliferation in human glioblastoma cell lines
AM Donson et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Share Paper
